Writing on unlisted markets, diligence, and how we operate the desk—the same editorial voice as the rest of the site.
Explore the Modern Diagnostic & Research Centre IPO, including issue details, business strengths, risks, and investment analysis.
Explore the Modern Diagnostic & Research Centre IPO, including issue details, business strengths, risks, and investment analysis.
Explore the MSAFE Equipments IPO, including issue details, business strengths, risks, and investment analysis.
Explore the NANTA TECH IPO, including issue details, business strengths, risks, and investment analysis.
Explore the Narmadesh Brass Industries IPO, including issue details, business strengths, risks, and investment analysis.
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
Anlon Healthcare Limited launched its book-built public offering worth ₹121.03 Crore. Review the crucial data points for investors, featuring the ₹86–₹91 price band, important listing windows, and a complete analysis of its active pharmaceutical ingredient (API) production base.